- Investing Ideas
- U.K. Pharmaceuticals & Biotech Profitable Climbers
U.K. Pharmaceuticals & Biotech Profitable Climbers
Results
2
1 new
2 companies
AstraZeneca
Market Cap: UK£215.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
New
AZN
UK£138.96
7D
-3.3%
1Y
21.3%
Animalcare Group
Market Cap: UK£176.1m
Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.
ANCR
UK£2.55
7D
-3.4%
1Y
16.4%